Helps patients with access, reimbursement support, and connection to resources
Stemline ARC provides access, reimbursement support, and connection to resources for eligible patients throughout treatment with ELZONRIS® (tagraxofusp-erzs) Injection for Intravenous (IV) Use. Enroll your patients now.
Permanent J-Code and NTAP designation for ELZONRIS Injection for IV Use, effective October 1, 2019
J-Code: J9269 Injection, tagraxofusp-erzs, 10 mcg
NTAP designation: XW033Q5 or XW043Q5*
Centers for Medicare & Medicaid Services (CMS) granted ELZONRIS Injection for IV Use a New Technology Add-On Payment (NTAP) designation for inpatient utilization†